An Open Label Study of Seroquel SR (Quetiapine) for the Treatment of Refractory and Treatment Resistant Functional Bowel Disorders.
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 20 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2011 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.